Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFUERZO: COVID-19 Vaccine Boosters after CoronaVac
NCT04992182Phase 2Unknown
- Sponsor
- Universidad del Desarrollo
- Start
- Jul 2021
- Primary completion
- Aug 2021
- Modality
- Viral Vector Vaccines, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of coronavac, tozinameran and ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by Universidad del Desarrollo. Status: unknown.
02
Drugs
coronavactozinameranChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04992182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04992182.